AlphAIalphai — Financial news for AI agents
SEC EDGAR 8-KAUG 201 min read$SBEV

SPLASH BEVERAGE GROUP, INC. (SBEV): Results of Operations and Financial Condition

SPLASH BEVERAGE GROUP, INC. (SBEV) filed an SEC Form 8-K — Results of Operations and Financial Condition. false 0001553788 0001553788 2026-08-20 2026-08-20 iso4217:USD xbrli:shares iso4217:USD xbrli:shares UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Repor

Original reporting
SEC EDGAR 8-K
Published Aug 20, 2026, 1:06 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 20, 2026, 1:10 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About alphai AI DeskScoring methodologyReport an issue
alphai market briefEarnings
Primary signal
$SBEV
Neutral
medium confidence
Mentioned
$SBEV
Relevance
7/10
alphai data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$SBEVNeutralLow
01

Why it matters

The filing confirms the company has released its Q2 2026 financials, but no quantitative details are included, limiting immediate trading decisions.

02

Market read

Primary disclosure of quarterly results; however, lack of numbers curtails actionable insight.

03

What to watch

Potential upcoming guidance or management commentary not yet released.

Relevance 7/10Novelty 5/10Timing: today

Background

SEC Form 8‑K filing provides the official channel for companies to disclose material events such as quarterly results.

Company-level read

Ticker impact

$SBEVNeutralMedium confidence
Context

Form 8‑K filed on Aug 20 2026 reporting the company's Q2 2026 results and financial condition.

Expected impact

Limited immediate impact pending detailed numbers.

Evidence & confidence

Primary source filing but lacking quantitative data reduces actionable insight.

Market effects

Sector

None disclosed; results pertain only to Splash Beverage Group.

Regional

U.S. market, limited broader effect.

Global

Minimal

Counterpoint

What could challenge this read

Without numbers, the filing may hide weaker performance.

Key entities

  • company
    Splash Beverage Group, Inc.

    Issuer of the Form 8‑K reporting Q2 results.

Read at source← All news

Related articles

JUL 31
$SBEVMed

Splash Beverage Group (SBEV) Stock Is Trending Overnight— Here's Why It Jumped 64% After Hours Splash Bev

Splash Beverage Group Inc. (NYSE:SBEV) shares are trending on Friday. Shares of the Florida-based company climbed 64.10% to $0.57 after the bell on Thursday. The surge in the late trading session follows an intraday gain of 7.07% which closed the SBEV at $0.35, according to Benzinga Pro data. Splash Beverage Group, which engages in the manufacturing, distribution, marketing, and sale of various beverages, experienced an exceptionally elevated trading session on Thursday.

benzinga.com5 min
JUL 29
$SBEVMed

Splash Beverage Group Expands CannEpil Platform into Veterinary Therapeutics, Establishing Second FDA-Regulated Pharmaceutical Development Program

Splash Beverage Group (NYSE American: SBEV) said it expanded its exclusive global CannEpil license to cover veterinary therapeutics. The company plans initial evaluation for companion-animal oncology and chronic pain, pursuing FDA Center for Veterinary Medicine INAD and Conditional Approval pathways. Splash will pay Argent BioPharma a 10% royalty on veterinary net revenues.

finanznachrichten.de4 min
JUL 14
$SBEVMedAI 8/10

Splash Beverage Group Announces Significant Balance Sheet Improvement and Board Approval of Reverse Stock Split as Company Continues Strategic Transformation

Splash Beverage Group (NYSE American: SBEV) said it settled legacy creditor claims totaling about $3.3 million for about $550,000 cash, expecting an approximate $2.75 million gain from debt extinguishment, subject to final accounting. Its board approved a 1-for-4 reverse stock split to support NYSE American minimum price compliance, reducing shares from ~25.2M to ~6.3M, effective July 27, 2026.

manilatimes.net4 min
JUL 9
$SBEVMed

Splash Beverage Group Receives NYSE American Acceptance of Compliance Plan, Establishing Defined Path Toward Continued Listing and Strategic Transformation

Splash Beverage Group (NYSE American: SBEV) said NYSE American accepted its plan to regain continued listing compliance and granted a compliance period through Jan. 29, 2027, after the company submitted the plan on May 29, 2026. The company said it will execute strategic initiatives while maintaining its listing.

manilatimes.net3 min
JUL 7
$SBEVMedAI 8/10

SPLASH BEVERAGE GROUP ACQUIRES EXCLUSIVE GLOBAL RIGHTS TO CANNEPIL®, AN EPILEPSY THERAPY WITH ESTABLISHED EUROPEAN PATIENT ACCESS, FDA ENGAGEMENT AND U.S. DEVELOPMENT POTENTIAL

Splash Beverage Group (NYSE American: SBEV) said it signed an exclusive global licensing deal with Argent BioPharma (ASX/LSE: RGT) for CannEpil, a cannabinoid-based investigational therapy for drug-resistant epilepsy. CannEpil is approved for distribution in multiple countries and has initiated U.S. pre-IND/IND steps. Splash received a $1M investment commitment and will issue $5.5M preferred equity; Argent debt (~$5M) is forgiven. Argent earns a 15% net-revenue royalty.

prnewswire.com3 min
JUL 6
$SBEVMed

Splash Beverage Group Secures Exclusive Global Rights To CannEpil For Drug- Resistant Epilepsy

Splash Beverage Group (SBEV) said it secured exclusive global licensing rights to CannEpil, a pharmaceutical-grade cannabinoid therapy for drug-resistant epilepsy, from Argent BioPharma (RGT.AX). CannEpil has patient access in Ireland, UK, Germany and Australia under EU-GMP, with Ireland MCAP reimbursement support and UK Named Patient Request import/prescription. SBEV cited pre-IND/IND progress for U.S. development.

rttnews.com4 min